Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Joshua B Cohen

CEO at Amylyx Pharmaceuticals, Inc. (AMLX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $4.0M

Reported trades

Filed Stock Type Shares Price Value Since
Sep 14SEC AMLXAmylyx Pharmaceuticals, Inc. Sell 29,5453,614,042 held (−1%) $32.16 $950K -12.5%
Sep 14SEC AMLXAmylyx Pharmaceuticals, Inc. Sell 9193,613,123 held (−0%) $33.15 $30K -15.1%
Mar 4SEC AMLXAmylyx Pharmaceuticals, Inc. Sell 29,2823,334,683 held (−1%) $14.48 $424K +94.3%
Feb 4SEC AMLXAmylyx Pharmaceuticals, Inc. Sell 15,5003,363,965 held (−0%) $14.68 $228K +91.7%
Jan 20SEC AMLXAmylyx Pharmaceuticals, Inc. Sell 136,1933,378,621 held (−4%) $13.59 $1.9M +107.1%
Jan 20SEC AMLXAmylyx Pharmaceuticals, Inc. Sell 1,9743,379,465 held (−0%) $13.83 $27K +103.5%
Jan 8SEC AMLXAmylyx Pharmaceuticals, Inc. Sell 7,7153,317,632 held (−0%) $11.09 $86K +153.7%
Oct 2SEC AMLXAmylyx Pharmaceuticals, Inc. Sell 29,7333,325,547 held (−1%) $14.34 $426K +96.2%
Oct 2SEC AMLXAmylyx Pharmaceuticals, Inc. Sell 2003,325,347 held (−0%) $15.00 $3K +87.6%